[Federal Register: April 8, 2008 (Volume 73, Number 68)]
[Notices]
[Page 19123-19125]
[DOCID:fr08ap08-98]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-57601; File No. SR-NYSE-2008-22]

Self-Regulatory Organizations; New York Stock Exchange LLC;
Notice of Filing and Immediate Effectiveness of a Proposed Rule Change
To Extend the Moratorium on the Qualification and Registration of New
Registered Competitive Market Makers and New Competitive Traders,
Governed by NYSE Rules 107A and 110, Respectively, for an Additional
Three Months

April 2, 2008.
    Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934
(``Act'') \1\ and Rule 19b-4 thereunder,\2\ notice is hereby given that
on March 26, 2008, the New York Stock Exchange LLC (``NYSE'' or
``Exchange'') filed with the Securities and Exchange Commission
(``Commission'') the proposed rule change as described in Items I and
II below, which Items have been substantially prepared by the Exchange.
The Commission is publishing this notice to solicit comments on the
proposed rule change from interested persons.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of the Terms of Substance
of the Proposed Rule Change

    The Exchange proposes to extend for three months the moratorium
related to the qualification and registration of Registered Competitive
Market Makers (``RCMMs''), pursuant to Exchange Rule 107A, and
Competitive Traders (``CTs''), pursuant to Exchange Rule 110
(``Moratorium''). The text of the proposed rule change is available at
http://www.nyse.com, the NYSE, and the Commission's Public Reference
Room.

II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, the Exchange included statements
concerning the purpose of, and basis for, the proposed rule change. The
text of these statements may be examined at the places specified in
Item IV below. The Exchange has prepared summaries, set forth in
Sections A, B, and C below, of the most significant aspects of such
statements.

A. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

1. Purpose
    The Exchange proposes to extend for three months the current
Moratorium related to the qualification and registration of RCMMs,
pursuant to Exchange Rule 107A, and CTs, pursuant to Exchange Rule 110.
    On September 22, 2005, the Exchange filed SR-NYSE-2005-63 \3\ with
the Commission proposing to implement a moratorium on the qualification
and registration of new RCMMs and CTs. The purpose of the Moratorium
was to allow the Exchange an opportunity to review the viability of
RCMMs and CTs in the NYSE HYBRID MARKET \SM\ (``Hybrid Market'').\4\
    During each phase of the Hybrid Market, new system functionality
was included in the operation of Exchange systems, and new data was
generated. As a result, the Exchange was unable to make an informed
decision as to the viability of RCMMs and CTs in the Hybrid Market. The
phased-in implementation of the Hybrid Market required the Exchange to
extend the Moratorium an additional five times over the next twenty-one
(21) months.\5\
---------------------------------------------------------------------------

    \3\ See Securities Exchange Act Release No. 52648 (October 21,
2005), 70 FR 62155 (October 28, 2005) (SR-NYSE-2005-63).
    \4\ See Securities Exchange Act Release No. 53539 (March 22,
2006), 71 FR 16353 (March 31, 2006) (SR-NYSE-2004-05) (establishing
the Hybrid Market).
    \5\ See Securities Exchange Act Release Nos. 54140 (July 13,
2006), 71 FR 41491 (July 21, 2006) (SR-NYSE-2006-48); 54985
(December 21, 2006), 72 FR 171 (January 3, 2007) (SR-NYSE-2006-113);
55992 (June 29, 2007), 72 FR 37289 (July 9, 2007) (SR-NYSE-2007-57);
56556 (September 27, 2007), 72 FR 56421 (October 3, 2007) (SR-NYSE-
2007-86); and 57072 (December 31, 2007), 73 FR 1252 (January 7,
2008) (SR-NYSE-2007-125).
---------------------------------------------------------------------------

    The Exchange is now proposing to extend the Moratorium, as
amended,\6\ for an additional three months to June 30, 2008 in order to
finalize its determination as to the roles of RCMMs and CTs in the
Exchange's Hybrid Market and to formally submit a proposal to the
Commission outlining the role, if any, these classes of traders have in
the Exchange's evolving market.
---------------------------------------------------------------------------

    \6\ See Securities Exchange Act Release No. 53549 (March 24,
2006), 71 FR 16388 (March 31, 2006) (SR-NYSE-2006-11) (making
certain amendments to the Moratorium).
---------------------------------------------------------------------------

    The Exchange continues to review the data related to RCMMs' and
CTs' current trading on the NYSE. Nevertheless, the Exchange is
currently undergoing significant developments in its technology and its
market model. Accordingly, the Exchange requests additional time to
decide what roles, if any, RCMMs and CTs should perform in the evolving
market model.
    The Exchange will issue an Information Memo announcing the
extension of the Moratorium.
2. Statutory Basis
    The basis under the Act \7\ for this proposed rule change is the
requirement under Section 6(b)(5) \8\ that an exchange have rules that
are designed to promote just and equitable principles of trade, to
remove impediments to and perfect the mechanism of a free and open
market and a national market system and, in general, to protect
investors and the public interest. The Exchange is currently reviewing
the data related to RCMMs and CTs to evaluate its trading volume in the
current, more electronic market. Since it is undergoing significant
developments in its technology and its market model, the Exchange
believes that an extension of time to finalize its determination of
what, if any, roles the RCMMs and CTs will play in this evolving
marketplace could potentially remove impediments to, and better
improve, the mechanism of a free and open market.
---------------------------------------------------------------------------

    \7\ 15 U.S.C. 78a.
    \8\ 15 U.S.C. 78f(b)(5).
---------------------------------------------------------------------------

B. Self-Regulatory Organization's Statement on Burden on Competition

    The Exchange does not believe that the proposed rule change will
impose any burden on competition that is not necessary or appropriate
in furtherance of the purposes of the Act.

C. Self-Regulatory Organization's Statement on Comments on the Proposed
Rule Change Received From Members, Participants, or Others

    The Exchange has neither solicited nor received written comments on
the proposed rule change.

III. Date of Effectiveness of the Proposed Rule Change and Timing for
Commission Action

    Because the proposed rule change: (i) Does not significantly affect
the protection of investors or the public interest; (ii) does not
impose any significant burden on competition; and (iii) does not become
operative for 30 days after the date of the filing, or such shorter
time as the Commission may designate if consistent with the protection
of investors and the public interest, the proposed rule change has
become effective pursuant to Section 19(b)(3)(A) of the Act \9\ and
Rule 19b-4(f)(6) thereunder.\10\
---------------------------------------------------------------------------

    \9\ 15 U.S.C. 78s(b)(3)(A).
    \10\ 17 CFR 240.19b-4(f)(6). Pursuant to Rule 19b-4(f)(6)(iii)
under the Act, the Exchange is required to give the Commission
written notice of its intent to file the proposed rule change, along
with a brief description and text of the proposed rule change, at
least five business days prior to the date of filing of the proposed
rule change, or such shorter time as designated by the Commission.
The Exchange has requested that the Commission waive the 5-day pre-
filing notice requirement. The Commission has determined to waive
this requirement to allow the Exchange to file its proposal to
extend the Moratorium, which expires on March 31, 2008, without
delay.
---------------------------------------------------------------------------

    A proposed rule change filed pursuant to Rule 19b-4(f)(6) under the
Act \11\ normally does not become operative for 30 days after the date
of its filing. However, Rule 19b-4(f)(6)(iii) \12\ permits the
Commission to designate a shorter time if such action is consistent
with the protection of investors and the public interest. The NYSE has
requested that the Commission waive the 30-day operative delay. The
Commission believes that waiving the 30-day operative delay is
consistent with the protection of investors and the public interest
because it would allow the Moratorium to continue without interruption
so that the Exchange may have additional time to make a final
determination as to the future roles of RCMMs and CTs in the Hybrid
Market, if any, and to file with the Commission a proposed rule change
outlining such roles. For these reasons, the Commission designates that
the proposed rule change become operative immediately.\13\
---------------------------------------------------------------------------

    \11\ 17 CFR 240.19b-4(f)(6).
    \12\ 17 CFR 240.19b-4(f)(6)(iii).
    \13\ For purposes only of waiving the 30-day operative delay,
the Commission has considered the proposed rule's impact on
efficiency, competition, and capital formation. 15 U.S.C. 78c(f).
---------------------------------------------------------------------------

    At any time within 60 days of the filing of the proposed rule
change, the Commission may summarily abrogate the rule change if it
appears to the Commission that such action is necessary or appropriate
in the public interest, for the protection of investors, or otherwise
in furtherance of the purposes of the Act.

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views and
arguments concerning the foregoing, including whether the proposed rule
change is consistent with the Act. Comments may be submitted by any of
the following methods:

Electronic Comments

     Use the Commission's Internet comment form (http://
www.sec.gov/rules/sro.shtml); or

     Send an e-mail to<EMAIL_ADDRESS>Please include
File Number SR-NYSE-2008-22 on the subject line.

Paper Comments

     Send paper comments in triplicate to Nancy M. Morris,
Secretary, Securities and Exchange Commission, 100 F Street, NE.,
Washington, DC 20549-1090.
All submissions should refer to File Number SR-NYSE-2008-22. This file
number should be included on the subject line if e-mail is used. To
help the Commission process and review your comments more efficiently,
please use only one method. The Commission will post all comments on
the Commission's Internet Web site (http://www.sec.gov/rules/
sro.shtml). Copies of the submission, all subsequent amendments, all
written statements with respect to the proposed rule change that are
filed with the Commission, and all written communications relating to
the proposed rule change between the Commission and any person, other
than those that may be withheld from the public in accordance with the
provisions of 5 U.S.C. 552, will be available for inspection and
copying in the Commission's Public Reference Room, on official business
days between the hours of 10 a.m and 3 p.m. Copies of the filing also
will be available for inspection and copying at the principal office of
the Exchange. All comments received will be posted without change; the
Commission does not edit personal identifying information from
submissions. You should submit only information that you wish to make
available publicly. All submissions should refer to File Number SR-
NYSE-2008-22 and should be submitted on or before April 29, 2008.

    For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\14\
---------------------------------------------------------------------------

    \14\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

Florence E. Harmon,
Deputy Secretary.
 [FR Doc. E8-7308 Filed 4-7-08; 8:45 am]

BILLING CODE 8011-01-P


[Federal Register Volume 85, Number 128 (Thursday, July 2, 2020)]
[Notices]
[Page 39913]
[FR Doc No: 2020-14284]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2020-N-1360]

Teva Branded Pharmaceutical Products R&D, Inc.; Withdrawal of
Approval of a New Drug Application for ZECUITY (Sumatriptan
Iontophoretic Transdermal System)

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is withdrawing the
approval of the new drug application (NDA) for ZECUITY (sumatriptan
iontophoretic transdermal system) held by Teva Branded Pharmaceutical
Products R&D, Inc. (Teva), 41 Moores Rd., P.O. Box 4011, Frazer, PA
19355. Teva requested withdrawal of this application and has waived its
opportunity for a hearing.

DATES: Approval is withdrawn as of July 2, 2020.

FOR FURTHER INFORMATION CONTACT: Kimberly Lehrfeld, Center for Drug
Evaluation and Research, Food and Drug Administration, 10903 New
Hampshire Ave. Bldg., 51, Rm. 6226, Silver Spring, MD 20993-0002, 301-
796-3137.

SUPPLEMENTARY INFORMATION: On January 17, 2013, FDA approved NDA 202278
for ZECUITY (sumatriptan iontophoretic transdermal system) for the
acute treatment of migraine with or without aura in adults. On June 2,
2016, FDA issued a Drug Safety Communication announcing the FDA is
investigating the risk of serious burns and potential permanent
scarring with the use of ZECUITY for migraine headaches. (https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-evaluating-risk-burns-and-scars-ZECUITY-sumatriptan-migraine-patch). On June 10, 2016, Teva suspended sales, marketing and
distribution to investigate the cause of burns and scars associated
with ZECUITY.
    On July 19, 2019, Teva requested withdrawal of NDA 202278 for
ZECUITY under Sec.  314.150(d) (21 CFR 314.150(d)) and waived its
opportunity for a hearing. In its letter requesting withdrawal of
approval, Teva stated that it voluntarily discontinued manufacture and
sale of products under NDA 202278 in 2016 for commercial reasons and
has agreed to withdrawal of the application for those reasons only.
    For the reasons discussed above, and pursuant to the applicant's
request, approval of NDA 202278 for ZECUITY (sumatriptan iontophoretic
transdermal system), and all amendments and supplements thereto, is
withdrawn under Sec.  314.150(d).
    Distribution of ZECUITY into interstate commerce without an
approved application is illegal and subject to regulatory action (see
sections 505(a) and 301(d) of the Federal Food, Drug, and Cosmetic Act
(21 U.S.C. 355(a) and 331(d)).

    Dated: June 22, 2020.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2020-14284 Filed 7-1-20; 8:45 am]
BILLING CODE 4164-01-P


[Federal Register Volume 77, Number 242 (Monday, December 17, 2012)]
[Notices]
[Pages 74670-74671]
[FR Doc No: 2012-30274]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2012-D-1145]

Draft Guidance for Industry on Enrichment Strategies for Clinical
Trials to Support Approval of Human Drugs and Biological Products;
Availability

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the
availability of a draft guidance for industry entitled ``Enrichment
Strategies for Clinical Trials to Support Approval of Human Drugs and
Biological Products.'' The purpose of this document is to provide
guidance to industry on enrichment strategies that can be used in
clinical trials intended to support effectiveness and safety claims in
new drug applications (NDAs) and biologics license applications (BLAs).
This document defines several types of enrichment strategies, provides
examples of various potential clinical trial designs, and discusses
potential regulatory considerations when using enrichment strategies in
clinical trials.

DATES: Although you can comment on any guidance at any time (see 21 CFR
10.115(g)(5)), to ensure that the Agency considers your comment on this
draft guidance before it begins work on the final version of the
guidance, submit either electronic or written comments on the draft
guidance by February 15, 2013.

ADDRESSES: Submit written requests for single copies of the draft
guidance to the Division of Drug Information, Center for Drug
Evaluation and Research, Food and Drug Administration, 10903 New
Hampshire Ave., Bldg. 51, Rm. 2201, Silver Spring, MD 20993-0002; or
the Office of Communication, Outreach and Development (HFM-40), Center
for Biologics Evaluation and Research, Food and Drug Administration,
1401 Rockville Pike, suite 200N, Rockville, MD 20852-1448 (1-800-835-
4709 or<PHONE_NUMBER>), or the Division of Small Manufacturers,
International and Consumer Assistance, Center for Devices and
Radiological Health, Food and Drug Administration, 10903 New Hampshire
Ave., Bldg. 66, Rm. 4613, Silver Spring, MD 20993-0002, or fax your
request to<PHONE_NUMBER>. Send one self-addressed adhesive label to
assist that office in processing your requests. See the SUPPLEMENTARY
INFORMATION section for electronic access to the draft guidance
document.
    Submit electronic comments on the draft guidance to http://www.regulations.gov. Submit written comments to the Division of Dockets
Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT: Robert Temple, Center for Drug
Evaluation and Research, Food and Drug Administration, 10903 New
Hampshire Ave., Bldg. 22, Rm. 4212, Silver Spring, MD 20993-0003, 301-
796-2270; or Stephen Ripley, Center for Biologics Evaluation and
Research, Food and Drug Administration, 1401 Rockville Pike, Suite
200N, Rockville, MD 20852-1448,<PHONE_NUMBER>; or Robert L. Becker,
Center for Device and Radiological Health, Food and Drug
Administration, 10903 New Hampshire Ave., Bldg. 66, Rm. 5674, Silver
Spring, MD 20993-0003,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

I. Background

    FDA is announcing the availability of a draft guidance for industry
entitled ``Enrichment Strategies for Clinical Trials to Support
Approval of Human Drugs and Biological Products.'' This document
provides guidance to industry on enrichment strategies that can be used
in clinical trials intended to support effectiveness and safety claims
in new drug applications (NDAs) and biologics license applications
(BLAs). Similar approaches could be used in clinical trials in earlier
phases of drug development. As part of the reauthorization of the
Prescription Drug User Fee Act (PDUFA IV), FDA committed to certain
performance goals (see letters from the Secretary of Health and Human
Services to the Chairman of the Committee on Health, Education, Labor,
and Pensions of the Senate and the Chairman of the Committee on Energy
and Commerce of the House of Representatives, as set forth in the

Congressional Record).\1\ This draft guidance addresses one of these
goals with the creation of a guidance document that addresses enriched
trial designs. The guidance defines and discusses three enrichment
strategies: Decreasing heterogeneity, predictive enrichment, and
prognostic enrichment. The guidance also discusses general clinical
trial design considerations, provides examples of potential clinical
trial designs, and discusses regulatory considerations when using
enrichment strategies.
---------------------------------------------------------------------------

    \1\ See ``Section A: PDUFA Reauthorization Performance Goals and
Procedures Fiscal Years 2008 Through 2012'' (http://www.fda.gov/ForIndustry/UserFees/PrescriptionDrugUserFee/ucm119243.htm).
---------------------------------------------------------------------------

    This draft guidance is being issued consistent with FDA's good
guidance practices regulation (21 CFR 10.115). The draft guidance, when
finalized, will represent the Agency's current thinking on clinical
trial designs employing enrichment strategies to support approval of
human drugs and biological products. It does not create or confer any
rights for or on any person and does not operate to bind FDA or the
public. An alternative approach may be used if such approach satisfies
the requirements of the applicable statutes and regulations.

II. Comments

    Interested persons may submit to the Division of Dockets Management
(see ADDRESSES) either electronic or written comments regarding this
document. It is only necessary to send one set of comments. Identify
comments with the docket number found in brackets in the heading of
this document. Received comments may be seen in the Division of Dockets
Management between 9 a.m. and 4 p.m., Monday through Friday.

III. Electronic Access

    Persons with access to the Internet may obtain the document at
either http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htm, http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/default.htm, http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/default.htm, or http://www.regulations.gov.

    Dated: November 20, 2012.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2012-30274 Filed 12-14-12; 8:45 am]
BILLING CODE 4160-01-P


[Federal Register: May 17, 2006 (Volume 71, Number 95)]
[Notices]
[Page 28718-28720]
[DOCID:fr17my06-90]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-53793; File No. SR-Amex-2005-103]

Self-Regulatory Organizations; American Stock Exchange LLC; Order
Granting Approval of Proposed Rule Change and Amendment Nos. 1, 2, 3
and 4 Thereto Allowing Issuers of Listed Equity Securities, Structured
Products, and Exchange Traded Funds a Right To Request a New Specialist

May 11, 2006.
    On October 13, 2005, the American Stock Exchange LLC (``Amex'' or
``Exchange'') filed with the Securities and Exchange Commission
(``Commission''), pursuant to Section 19(b)(1) of the Securities
Exchange Act of 1934 (``Act'') \1\ and Rule 19b-4 thereunder,\2\ a
proposed rule change to amend Amex Rule 27 to give issuers of listed
equity securities and structured products, as well as sponsors of
exchange traded funds (``ETFs''), a right to request a new specialist.
On January 26, 2006, Amex filed Amendment No. 1 to the proposed rule
change.\3\ On January 30, 2006, Amex filed Amendment No. 2 to the
proposed rule change.\4\ On February 17, 2006, Amex filed Amendment No.
3 to the proposed rule change.\5\ On March 6, 2006, Amex filed
Amendment No. 4 to the proposed rule change.\6\ The proposed rule
change, as amended, was published for comment in the Federal Register
on April 4, 2006.\7\ The Commission received no comments on the
proposal. This order approves the proposed rule change, as amended.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
    \3\ In Amendment No. 1, the Exchange proposed further changes to
Amex Rule 27(e) and (f) and made revisions to the purpose section of
the proposed rule change.
    \4\ In Amendment No. 2, the Exchange made revisions to the
purpose section of the proposed rule change to reflect changes to
the text of Amex Rule 27(f) made in Amendment No. 1
    \5\ In Amendment No. 3, the Exchange proposed further changes to
Amex Rule 27(e) and (f) and made revisions to the purpose section of
the proposed rule change.
    \6\ In Amendment No. 4, the Exchange proposed minor technical
changes to the text of Amex Rule 27(e) and (f).
    \7\ See Securities Exchange Act Release No. 53561 (March 29,
2006), 71 FR 16841.
---------------------------------------------------------------------------

I. Description of the Proposal

    Amex Rule 27(e) currently gives the issuer of an equity security or
a structured product and the sponsor of an ETF a one-time right to
request a reallocation to a different specialist unit within twelve
months after the listing of the security.

    The Exchange proposed to amend Amex Rule 27(e)(ii) to permit the
issuer of an equity security or structured product or the sponsor of an
ETF to request a specialist reassignment for ``good cause'' by filing a
written notice (``Notice'') with the officer in charge of Equities
Administration or the officer in charge of the ETF Marketplace, as
applicable. The Notice must indicate the specific issues prompting the
request and any steps previously taken to attempt to address these
issues. Amex proposes to define ``good cause'' as the failure of the
specialist to make competitive markets; the failure of the specialist
unit to risk capital commensurate with the type of security; the
failure of the specialist unit to assign competent personnel to the
securities; or any statements made publicly by the specialist unit that
substantially denigrate the security.
    Further, the proposed revisions to Amex Rule 27(e) would require
that copies of the Notice be provided to the Chief Regulatory Officer
of the Exchange (``CRO'') and to the Exchange's Committee on Floor
Member Performance. In addition, the subject specialist unit would be
notified that a mediation is being commenced with respect to the
request for reassignment, and would be provided a copy of the Notice.
The specialist unit may submit a written response within two weeks
(``Specialist Response Date''), which response must be provided to the
CRO and the Committee on Floor Member Performance. If the specialist
unit does not submit a response during this two-week time period, there
will be no mediation. In such case, the Allocations Committee will be
convened to reallocate securities pursuant to Amex Rule 27(b).
    The CRO would review the Notice and any specialist response, and
may request a review of the matter by the Regulatory Oversight
Committee (``ROC'') of the Exchange's Board of Governors. In addition,
the Committee on Floor Member Performance would review the Notice and
any specialist response. Prior to the commencement of the mediation,
the Committee on Floor Member Performance would make any determination
that ``good cause'' does not exist. A determination that ``good cause''
does not exist would preclude the commencement of a mediation. In this
circumstance, the security would not be reallocated and the issuer or
sponsor may request an appeal of the decision of the Committee on Floor
Member Performance to be heard by the Amex Adjudicatory Council.\8\ If
the decision of the Committee on Floor Member Performance is upheld,
then the security will not be reallocated.
---------------------------------------------------------------------------

    \8\ See Article II, Section 7(a) of the Amex Constitution.
---------------------------------------------------------------------------

    The mediation of the issues that have arisen between the issuer or
sponsor and the specialist unit may be conducted pending the outcome of
the CRO's and, if applicable, the ROC's review of the request. However,
where a review by the ROC has been requested, no change of specialist
unit may occur until the ROC makes a final determination that it is
appropriate to permit such change. In making such determination, the
ROC may consider all relevant regulatory issues, including without
limitation whether the requested change appears to be in aid or
furtherance of conduct that is illegal or violates Exchange rules, or
in retaliation for a refusal by a specialist to engage in conduct that
is illegal or violates Exchange rules. Notwithstanding reviews by the
CRO, ROC and/or Committee on Floor Member Performance of any matter
raised during the process described herein, the Amex Division of
Regulation and Compliance (including Listing Qualifications) and/or the
NASD Amex Division may at any time take any regulatory action that it
may determine to be warranted. The Amex represents that reassignment
may not occur without prior notice that the CRO has decided not to
refer the matter to the ROC or that the ROC has determined that the
change is appropriate.
    A Mediation Committee would be appointed and would consist of at
least one floor broker, one senior floor official, one upstairs
governor, and two independent governors for each mediation.\9\ The
Mediation Committee would meet with representatives of the issuer or
sponsor and the specialist unit in an attempt to mediate the matters
indicated in the Notice. During the course of the mediation, the issuer
or sponsor may conclude the mediation if it determines that it wishes
to continue with the same specialist unit. In the alternative, after
the expiration of one month from the time of the specialist's response,
subject to the conclusion of any review by the CRO and ROC, the issuer
or sponsor may file written notice, signed by the issuer's or sponsor's
chief executive officer, that it wishes to proceed with the change of
specialist unit. The new specialist unit would be selected by the
Allocations Committee pursuant to Amex Rule 27(b).
---------------------------------------------------------------------------

    \9\ The Exchange represents that the Mediation Committee would
consist of at least one floor broker, at least one senior floor
official, at least one upstairs governor, and at least two
independent governors for each mediation. Telephone conversation
between Nyieri Nazarian, Assistant General Counsel, Amex and David
Michehl, Special Counsel, Division of Market Regulation, Commission
on May 11, 2006.
---------------------------------------------------------------------------

    Finally, the Exchange proposes to amend Amex Rule 27(f) to provide
that, in addition to the circumstances provided for in the existing
rule, the Allocations Committee would be convened to reallocate
securities when an issuer or sponsor files a written notice requesting
a change of specialist unit and the Mediation Committee orders
reallocation pursuant to proposed paragraph (e)(viii) of Amex Rule 27,
or an issuer or sponsor files a written notice requesting a change of
specialist unit and the specialist unit does not submit a response.

II. Discussion

    The Commission finds that the proposed rule change, as amended, is
consistent with the requirements of Section 6 of the Act,\10\ and the
rules and regulations thereunder applicable to a national securities
exchange.\11\ In particular, the Commission finds that the proposed
rule change is consistent with Section 6(b)(5) of the Act,\12\ which
requires, among other things, that the Exchange's rules be designed to
prevent fraudulent and manipulative acts and practices, to promote just
and equitable principles of trade, and, in general, to protect
investors and the public interest.
---------------------------------------------------------------------------

    \10\ 15 U.S.C. 78f(b).
    \11\ In approving this proposed rule change, as amended, the
Commission has considered the proposed rule's impact on efficiency,
competition, and capital formation. 15 U.S.C. 78c(f).
    \12\ 15 U.S.C. 78f(b)(5).
---------------------------------------------------------------------------

    The Commission believes that the proposed rule change, as amended,
appropriately balances the need to revise the current Amex process by
which issuers of equity securities or structured products or sponsors
of ETFs request a new specialist with the need to incorporate
appropriate procedures that are designed to provide that any such
request is subject to mediation and review by the Exchange's Committee
on Floor Member Performance and CRO and, if requested by the CRO, the
ROC. While the proposal revises current time frame during which an
issuer or sponsor may request a new specialist, it also introduces the
involvement of the Exchange's Committee on Floor Member Performance and
CRO to assure that the requested change of specialist unit is for a
proper purpose. The Committee on Floor Member Performance and CRO would
be provided copies of any Notice and response to such Notice by the
specialist unit. When the CRO has

requested a review by the ROC, no change of specialist unit may occur
until after the ROC makes a final determination that it is appropriate
to permit such a change.
    The ROC, in making its determination of whether to permit a change
in specialist unit, may consider all relevant regulatory issues,
including whether the requested change appears to be in aid or
furtherance of conduct that is illegal or violates Exchange rules, or
is in retaliation for a refusal by a specialist to engage in conduct
that is illegal or violates Exchange rules. The Amex Division of
Regulation and Compliance and/or the NASD Amex Division may at any time
take any regulatory action that it may determine to be warranted.
Therefore, the Commission believes that the proposed process would
provide an appropriate mechanism for the Exchange to maintain
independent oversight over an issuer's or sponsor's request to change
specialist units, to ascertain that such requests are confined to
proper reasons, and to obtain a review by the ROC when appropriate.
    The Commission notes that the proposed rule change requires the
Mediation Committee to commence to meet with representatives of the
issuer or sponsor and the specialist unit ''as soon as practicable''
after the Specialist Response Date and does not limit the Mediation
Committee's attempt to mediate the matters indicated in the Notice. The
proposal further provides that the issuer or sponsor may at any time
file a written notice stating that it wishes to conclude the mediation
because it wishes to continue with the same specialist unit. After the
expiration of one month from the Specialist Response Date, the issuer
or sponsor may file a notice that it wishes to proceed with the change
of specialist unit. The Commission believes that the proposed process
is designed to provide the issuer or sponsor and the specialist unit
ample opportunity to attempt to resolve the issues that prompted the
issuer or sponsor to seek a new specialist unit and to allow the issuer
or sponsor to seek a new specialist unit a reasonable period of time
after the issuer or sponsor files its Notice.
    Accordingly, the Commission finds that the proposed rule change, as
amended, is consistent with the Act.
    It is therefore ordered, pursuant to Section 19(b)(2) of the
Act,\13\ that the proposed rule change (SR-Amex-2005-103), as amended,
is approved.
---------------------------------------------------------------------------

    \13\ 15 U.S.C. 78s(b)(2).
    \14\ 17 CFR 200.30-3(a)(12).

    For the Commission, by the Division of Market Regulation,
pursuant to delegated authority.\14\
Jill M. Peterson,
Assistant Secretary.
[FR Doc. E6-7463 Filed 5-16-06; 8:45 am]

BILLING CODE 8010-01-P


[Federal Register Volume 87, Number 175 (Monday, September 12, 2022)]
[Notices]
[Pages 55872-55876]
[FR Doc No: 2022-19579]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-95674; File No. SR-LCH SA-2022-007]

Self-Regulatory Organizations; LCH SA; Notice of Filing of
Proposed Rule Change Relating To Providing Clearing Services for
Additional Index and Single Name CDS

September 6, 2022.
    Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934
(``Act'' or ``Exchange Act''),\1\ and Rule 19b-4 thereunder,\2\ notice
is hereby given that on August 29, 2022, Banque Centrale de
Compensation, which conducts business under the name LCH SA (``LCH
SA''), filed with the Securities and Exchange Commission
(``Commission'' or ``SEC'') the proposed rule change (``Proposed Rule
Change'') described in Items I, II and III below, which Items have been
primarily prepared by LCH SA. The Commission is publishing this notice
to solicit comments on the Proposed Rule Change from interested
persons.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
---------------------------------------------------------------------------

I. Clearing Agency's Statement of the Terms of Substance of the
Proposed Rule Change

    LCH SA is proposing to expand its CDSClear service to provide
clearing services for additional index and single name credit default
swaps (``CDS''). Specifically, LCH SA is proposing to provide clearing
services with regard to the iTraxx Asia ex Japan Index, the Markit CDX
Emerging Markets (``CDX.EM'') Index and the single names that comprise
each index, as well as a list of additional sovereign single names
which are not constituent of an index (all together the ``New
Products''). To expand its clearing services in this way, LCH SA is
proposing to amend its CDS Clearing Supplement (the ``Supplement'') and
Section 2 of the CDS Clearing Procedures (the ``Procedures'') to
accommodate these additional indices and single names. LCH SA is
further proposing to amend its CDS Margin Framework and CDS Default
Fund Methodology (Guide Stress Testing) to reflect the addition of the
New Products in the scope of instruments eligible for clearing by
members of LCH SA CDSClear service.
    The text of the Proposed Rule Change is in Exhibit 5.\3\
---------------------------------------------------------------------------

    \3\ Capitalized terms used but not defined herein shall have the
meaning specified in the CDS Clearing Rule Book or the Clearing
Supplement, as applicable.
---------------------------------------------------------------------------

    The launch of the various initiatives reflected in the Proposed
Rule Change will be contingent upon LCH SA's receipt of all necessary
regulatory approvals, including the approval by the Commission of the
Proposed Rule Change described herein.

II. Clearing Agency's Statement of the Purpose of, and Statutory Basis
for, the Proposed Rule Change

    In its filing with the Commission, LCH SA included statements
concerning the purpose of and basis for the Proposed Rule Change and
discussed

any comments it received on the Proposed Rule Change. The text of these
statements may be examined at the places specified in Item IV below.
LCH SA has prepared summaries, set forth in sections A, B, and C below,
of the most significant aspects of such statements.

A. Clearing Agency's Statement of the Purpose of, and Statutory Basis
for, the Proposed Rule Change

1. Purpose
    The Proposed Rule change is being adopted to expand LCH SA's
CDSClear service to provide clearing services for additional index and
single name CDS. Specifically, LCH SA is proposing to provide clearing
services with regard to the iTraxx Asia ex Japan Index, the CDX.EM
Index and the single names that comprise each index, as well as a list
of additional sovereign single names which are not constituent of an
index.
    LCH SA has determined that the existing CDSClear risk model
currently appropriately takes into account the risk associated with the
New Products but is proposing to amend both its CDS Margin Framework
and CDS Default Fund Methodology (Guide Stress testing) in order to
reflect the addition of the New Products to the list of instruments
eligible for clearing. To accommodate the New Products, LCH SA is
further proposing to amend the Supplement and Section 2 of the
Procedures.
(a) The CDS Clearing Supplement
    To accommodate the New Products, LCH SA is proposing to amend the
following definitions set out in Section 1.2 of Part B of the
Supplement: (i) ``Compression Cut-off Date''; (ii) ``Novation Cut-off
Date''; (iii) ``Index Cleared Transaction Confirmation''; and (iv)
``Transaction Business Day''.
    Specifically, the definitions of ``Compression Cut-off Date'' and
``Novation Cut-off Date'' are each being amended to add two additional
credit events that are taken into consideration in determining the
``Compression Cut-off Date'' and ``Novation Cut-off Date'': (i) the
``Obligation Acceleration Credit Event''; and (ii) the ``Repudiation/
Moratorium Credit Event''. These credit events, which are both standard
under the 2014 ISDA Credit Derivatives Definitions, are not credit
events that apply to any of the transaction types referenced by CDS
that are currently eligible for clearing at LCH SA and, therefore, did
not previously need to be addressed in the Supplement. These credit
events apply to certain transaction types for sovereigns, and are
proposed to be added as a result of index comprising of and single name
CDS referencing sovereign reference entities becoming eligible for
clearing.
    In addition, the definition of ``Index Cleared Transaction
Confirmation'' is proposed to be revised to provide that: (i) with
regard to any index cleared transaction that references a Markit iTraxx
ex Japan Index Series [27] or above, the confirmation will be the form
of confirmation that incorporates the iTraxx Asia/Pacific Untranched
Standard Terms Supplement; and (ii) with regard to any index cleared
transaction that references a Markit CDX.EM Index Series [27] or above,
the form of confirmation that incorporates the CDX Emerging Markets
Untranched Transactions Standard Terms Supplement, in each case being
the latest version in force as published by Markit North America, Inc.
    The definition of a ``Transaction Business Day'' is currently
defined to mean a ``Business Day'', as defined in the Index Cleared
Transaction Confirmation or the Single Name Cleared Transaction
Confirmation, as applicable. This term is proposed to be amended to
take into account the situation where such confirmations could include
different definitions of the term ``Business Day'' depending on the
circumstances by providing that, ``if the relevant Index Cleared
Transaction Confirmation or Single Name Cleared Transaction
Confirmation defines such term differently depending upon its use, such
distinction shall also apply to the use of the term Transaction
Business Day herein.''
    In Section 2 of Part B of the Supplement, LCH SA is proposing to
amend Section 2.2 (Index Cleared Transaction Confirmation) which
specifies the manner in which an Index Cleared Transaction Confirmation
is amended, supplemented and completed depending on the index CDS that
is cleared to include, in addition to the indices currently set out in
the section, the iTraxx Asia ex Japan Index and the CDX.EM Index and
provide for the necessary amendments to be made to the relevant
confirmations depending on the index. Section 2.2 is also proposed to
be amended to provide that ``The applicable Physical Settlement Matrix
is the version of the Physical Settlement Matrix which is in force on
the Clearing Day on which the Index Cleared Transaction is registered
by LCH SA'' in a new indent (i) of paragraph (f). The purpose of this
amendment is to ensure that the Additional Provisions for Certain
Russian Entities published by ISDA on March 25, 2022 will apply to the
relevant cleared trades, including the trades submitted through the
backloading cycle that could have been entered into before the
implementation date of these Additional Provisions and updated Physical
Settlement Matrix and for which one of the parties, or both, did not
adhere to the ISDA 2022 Russia Additional Provisions Protocol published
by ISDA on March 29, 2022.
    In Section 4 of Part B of the Supplement, LCH SA is proposing to
amend Section 4.1(b) to add a ``Repudiation/Moratorium Extension
Notice'' to the types of notices that neither LCH SA nor a clearing
member is entitled to deliver with regard to an M(M)R Restructuring in
accordance with the terms of any Restructuring Cleared Transaction. As
above, a ``Repudiation/Moratorium Extension Notice'' is standard under
the 2014 ISDA Credit Derivatives Definitions and is being proposed to
be added as a result of index comprising of and single name CDS
referencing sovereigns becoming eligible for clearing.\4\
---------------------------------------------------------------------------

    \4\ For the same reason, ``Repudiation/Moratorium Extension
Notice'' is proposed to be added to Section 5(b) of Appendix XIII of
Part B of the Supplement (CCM Client Transaction Requirements).
---------------------------------------------------------------------------

    In Section 6 of Part B of the Supplement, Section 6.5(c) is
proposed to be amended to add ``Package Observable Bond'' to the types
of asset packages that can be identified in a Notice of Physical
Settlement (``NOPS'') or a NOPS Amendment Notice. The Package
Observable Bond provisions in the 2014 ISDA Credit Derivatives
Definitions only apply to transactions referencing sovereigns. As a
result, they did not previously need to be referenced in the
Supplement.
    LCH SA is also proposing to add a new section 6.8(c) entitled
``Buy-in of Bonds--Cap on Settlement'' for the purposes of clarifying
how the ``60 Business Day Cap on Settlement'', which is relevant for
transactions derived from the CDX EM Index amongst others, will apply
to CCM Client Transactions in respect of the Matched Contracts of a
Settlement Matched Pair. This proposed amendments consist in making an
adjustment as to the manner in which Section 9.10 of the 2014 ISDA
Credit Derivatives Definitions works between Matched Buyer and Matched
Seller to ensure that the extension of the Termination Date provided
for by Section 9.10 will apply when there has been a notice delivered
to Matched Seller by its client under a CCM Client Transaction. This is
to ensure that the Termination Date of the Cleared

Transactions and related CCM Client Transaction is the same.\5\
---------------------------------------------------------------------------

    \5\ For the same reason, the provisions of section 6.8(c) are
effectively repeated in Section 7.8 and Section 7.18 of Appendix
XIII of Part B of the Supplement (CCM Client Transaction
Requirements). Separately, Section 7.15 of Appendix XIII,
Alternative Procedures relating to Loans in respect of Matched
Contracts, and Section 7.17 of Appendix XIII, Alternative Procedures
relating to Assets Not Delivered, are proposed to be amended to
remove as unnecessary the phrase ``for the purposes of the Matched
Contracts of the related Settlement Matched Pair'' and also to use
the correct defined term ``Settlement Matched Pair''.
---------------------------------------------------------------------------

(b) Section 2 of the Procedures
    LCH SA is also proposing to make one minor technical amendment to
Section 2 of the Procedures (Margin, NPV Payment and Price Alignment).
Specifically, the initial sentence of Section 2.7(c) currently
provides, inter alia, that, where a Clearing Member is acting as a CDS
Seller, Short Charge Margin will be required to cover the risk that the
Clearing Member is subject to an event of default at the same time that
a credit event occurs ``with respect to a Reference Entity''.
Recognizing that a credit event may occur with respect to more than one
Reference Entity, this sentence is proposed to be revised to refer to
``one or more Reference Entities''.
(c) The Reference Guide: CDS Margin Framework
    LCH SA is proposing to amend the Margin Framework to reflect the
addition of the new single names. For example, Section 3.4.5, Portfolio
Margining, which, inter alia, lists the various combinations of
instruments that can constitute an index basis package, is proposed to
be revised to add to the list (i) the CDX.EM Index vs All Single Names
Constituents of the index and (ii) the iTraxx Asia ex Japan vs All
Single Names Constituents of the index. In addition, LCH SA is
proposing to amend Section 3.1.1, Recovery Rate for Short Charge to
note that the recovery rate for state-owned enterprises (``SOE'') is 70
percent. LCH is also proposing to move the provisions of current
Section 3.5.2, Short Charge Calculation, to a new Section 3.5.3. A new
Section 3.5.2, Sovereign Exposures, is proposed to be added, which
notes the high level of correlation between SOEs and their sovereign
entities. As a result, an SOE that is more than 50 percent owned by a
sovereign entity would be defaulted jointly with its sovereign entity
when the positions are not risk reducing. Further, exposures for SOEs
will be calculated using a fixed 70 percent recovery rate.
    LCH SA is also proposing to amend Section 3.8.1, Offsets inter-
region, to expand the regional pairs that LCH SA will consider in
calculating wrong way risk to include: (i) Europe/US; (ii) Europe/
Australia; (iii) Europe/Asia; (iv) US/Australia; (v) US/Asia; and (vi)
Asia/Australia.
    LCH SA is proposing to amend Section 4.1.1, Liquidity Charge for
Linear Portfolio, to note that the liquidation cost of a sub-portfolio
composed of a single 5 year position in the principal on the run index
is simply the sum of the macro hedging cost. Further, single names
without a parent index are considered a sub-portfolio for which LCH SA
charges the cost of unwinding a non-hedged sub-portfolio. Finally,
Section 4.1.2, Macro Hedging Phase, which, inter alia, sets out a list
of sub-portfolios corresponding to indices and their components is
proposed to be revised to add: (i) the CDX.EM sub-portfolio; (ii) the
iTraxx Asia ex Japan IG sub-portfolio, and (iii) the No parent index
sub-portfolio.
    LCH SA is proposing to amend Section 4.1.7 to update the existing
thresholds and include more cleared indexes in the table for volume
thresholds based on calibrations done in December 2021. A dedicated
liquidity grid has also been added for sovereign single names in order
to reflect their tighter bid-ask spreads and higher liquidity profiles.
    LCH SA is also proposing to amend the CDS Default Fund Methodology
(Guide Stress Testing) in a number of sections, to reflect the
extension of the product offer as well as to introduce a Sovereign
Stressed Short Charge component aimed to capture a potential joint
default of a member and its country:

--the last paragraph of section 2.2 adds to the list of index families
covered to reflect the addition of CDX.EM and iTraxx Asia. It also adds
iTraxx Australia, as this should have been updated when introducing
that index.
--section 2.4.1 details how State-Owned Entities' exposures should be
added to the exposure on the sovereign name only if risk increasing
--section 2.4.2 introduces a Sovereign Stressed Short Charge,
considering jointly the top exposure across the portfolio and if
relevant the exposure on the sovereign name corresponding to the
member's jurisdiction
--section 2.4.3. and 2.7.2 describe the same Sovereign Stressed Short
Charge with formulas instead of plain text
--section 2.6.1. and 2.6.3 extend the logic of exercise decisions to
consider the Sovereign Stressed Short Charge when relevant
2. Statutory Basis
    LCH SA believes that the Proposed Rule Change is consistent with
the requirements of Section 17A of the Act \6\ and regulations
thereunder applicable to it, including Commission Rule 17Ad-22(e).\7\
In particular, Section 17A(b)(3)(F) of the Act requires, inter alia,
that the rules of a clearing agency be designed to ``promote the prompt
and accurate clearance and settlement of . . . derivatives agreements,
contracts, and transactions.'' \8\ By proposing to amend its CDS
Clearing Supplement to authorize the expansion of LCH SA's CDSClear
Service to provide clearing services with regard to the New Products,
on the terms and conditions set out in the Proposed Rule Change, LCH SA
considers that this would encourage Clearing Members to clear
additional indices and single name CDS through its CDSClear service,
which, in turn, should promote the prompt and accurate clearance and
settlement of those instruments within the meaning of Section
17A(b)(3)(F) of the Act.\9\ The Proposed Rule Change, in particular,
the amendments to the CDS Clearing Supplement, therefore, are
consistent with the requirements of Section 17A(b)(3)(F) of the Act.
---------------------------------------------------------------------------

    \6\ 15 U.S.C. 78q-1.
    \7\ 17 CFR 240.17Ad-22.
    \8\ 15 U.S.C. 78q-1(b)(3)(F).
    \9\ 15 U.S.C. 78q-1(b)(3)(F).
---------------------------------------------------------------------------

    Further, from the perspective of financial risk management and
margin requirements, the clearing of the New Products would not require
changes to LCH SA's existing margin methodology, default management
policies and procedures and operational process, as LCH SA determined
that the current margin framework for its CDSClear service already
appropriately captures the risk associated to the New Products. The New
Products would be cleared pursuant to LCH SA's existing clearing
arrangements and related financial safeguards, protections and risk
management procedures which are consistent with Exchange Act Rule 17Ad-
22(e)(17),\10\ requiring a covered clearing agency to establish,
implement, maintain and enforce written policies and procedures
reasonably designed to manage the covered clearing agency's operational
risks by, among other things, identifying the plausible sources of
operational risk, both internal and external, and mitigating their
impact through the use of appropriate systems, policies, procedures,
and controls.
---------------------------------------------------------------------------

    \10\ 17 CFR 240.17Ad-22(e)(17).
---------------------------------------------------------------------------

    Adopting rules to facilitate the clearing of the New Products would
also be consistent with other relevant

requirements of Rule 17Ad-22(e),\11\ as set forth in the following
discussion.
---------------------------------------------------------------------------

    \11\ 17 CFR 240.17Ad-22(e).
---------------------------------------------------------------------------

    Margin Requirements. Rule 17Ad-22(e)(4) \12\ requires LCH SA to
establish, implement, maintain, and enforce written policies and
procedures reasonably designed to effectively identify, measure,
monitor, and manage its credit exposures to participants and those
arising from its payment, clearing, and settlement processes, among
other requirements. In terms of financial resources, LCH SA would apply
its existing margin methodology to the New Products. LCH SA believes
that the proposed rules that would apply this risk model to the New
Products will provide sufficient margin requirements to cover its
credit exposure to its clearing members from clearing such contracts,
consistent with the requirements of Rule 17Ad-22I(4).\13\ [sic]
---------------------------------------------------------------------------

    \12\ 17 CFR 240.17Ad-22(e)(4).
    \13\ 17 CFR 240.17Ad-22(e)4.
---------------------------------------------------------------------------

    Financial Resources. Rule 17Ad-22I(4)(i) \14\ [sic] requires LCH SA
to establish, implement, maintain, and enforce written policies and
procedures reasonably designed to effectively identify, measure,
monitor, and manage its credit exposures to participants and those
arising from its payment, clearing, and settlement processes by
maintaining sufficient financial resources to cover its credit exposure
to each participant fully with a high degree of confidence. To the
extent not already maintained pursuant to paragraph (e)(4)(i), Rule
17Ad-22(e)(4)(ii) \15\ requires LCH SA's policies and procedures be
reasonably designed to maintain additional financial resources at the
minimum to enable it to cover a wide range of foreseeable stress
scenarios that include, but are not limited to, the default of the two
participant families that would potentially cause the largest aggregate
credit exposure for the covered clearing agency in extreme but
plausible market conditions. As explained above, LCH SA is proposing to
make some changes to its CDS Default Fund Methodology documentation
(Guide Stress Testing) in order to reflect the extension of the product
list as well as to introduce a Sovereign Stressed Short Charge
component aimed to capture a potential joint default of a member and
its country. LCH SA believes that with the proposed changes in its
stress testing framework, its Default Fund will, together with the
required margin, provide sufficient financial resources to support the
clearing of the New Products, consistent with the requirements of Rules
17Ad-22(e)(4)(i) and (ii).
---------------------------------------------------------------------------

    \14\ 17 CFR 240.17Ad-22(e)(4)(i).
    \15\ 17 CFR 240.17Ad-22(e)(4)(ii).
---------------------------------------------------------------------------

    Operational Resources. Rule 17Ad-22(e)(3) \16\ requires LCH SA to
establish, implement, maintain, and enforce written policies and
procedures reasonably designed to maintain a sound risk management
framework for comprehensively managing legal, credit, liquidity,
operational, general business, investment, custody, and other risks
that arise in or are borne by the covered clearing agency. LCH SA
believes that its existing operational and risk management resources
will be sufficient for clearing of the New Products, consistent with
the requirements of Rule 17Ad-22(e)(3) \17\, as these new contracts are
substantially the same from an operational and risk management
perspective as the existing CDS contracts cleared by LCH SA CDSClear.
---------------------------------------------------------------------------

    \16\ 17 CFR 240.17Ad-22(e)(3).
    \17\ 17 CFR 240.17Ad-22(e)(3).
---------------------------------------------------------------------------

    LCH SA will also apply its existing default management policies and
procedures for the New Products. As with current CDSClear products with
similar risk profile, LCH SA believes that these procedures allow for
it to take timely action to contain losses and liquidity pressures and
to continue meeting its obligations in the event of clearing member
insolvencies or defaults in respect of the additional single names, in
accordance with Rule 17Ad-22(e)(3).\18\
---------------------------------------------------------------------------

    \18\ 17 CFR 240.17Ad-22(e)(3).
---------------------------------------------------------------------------

    Exchange Act Rule 17Ad-22(e)(1) \19\ requires that a covered
clearing agency establish, implement, maintain, and enforce written
policies and procedures reasonably designed to provide for a well-
founded, clear, transparent, and enforceable legal basis for each
aspect of its activities in all relevant jurisdictions. As described
above, the Proposed Change is also modifying the Supplement to take
into account the New Products and provide for a clear and transparent
legal basis for LCH SA's CDS Clearing rules consistent with the
requirements of Exchange Act Rule 17Ad-22(e)(1).\20\
---------------------------------------------------------------------------

    \19\ 17 CFR 240.17Ad-22(e)(1).
    \20\ 17 CFR 240.17Ad-22(e)(1).
---------------------------------------------------------------------------

    Credit default swap (CDS) is an over-the-counter (OTC) market on
which participants can be active at any time in the context of market
stress. The LCH SA CDSClear risk model is considering 5-d moves of
unhedged portfolios and the back testing results confirmed that the
margins for the New Products were sufficient to cover the exposure in
the interval between the last margin collection and the close out of
the portfolio a defaulting cleating member which is consistent with the
requirements of SEC Rule 17Ad-22(e)(6)(iii).\21\
---------------------------------------------------------------------------

    \21\ 17 CFR 240. 17Ad-22(e)(6)(iii).
---------------------------------------------------------------------------

B. Clearing Agency's Statement on Burden on Competition

    Section 17A(b)(3)(I) of the Act requires that the rules of a
clearing agency not impose any burden on competition not necessary or
appropriate in furtherance of the purposes of the Act.\22\
---------------------------------------------------------------------------

    \22\ 15 U.S.C. 78q-1(b)(3)(I).
---------------------------------------------------------------------------

    LCH SA does not believe that its proposed clearing of the New
Products will adversely affect competition in the trading market for
those contracts or CDS generally. By allowing LCH SA to clear the New
Products, market participants will have additional choices on where to
clear and which products to use for risk management purposes, which, in
turn, will promote competition and further the development of CDS for
risk management.
    In addition, LCH SA will continue to apply its existing fair and
open access criteria to the clearing of these additional products and
will apply the same criteria to every clearing member or client who
proposes to enter into this clearing activity.
    Accordingly, LCH SA does not believe that the Proposed Rule Change
would impose any burden on competition that is not necessary or
appropriate in furtherance of the purposes of the Act.

C. Clearing Agency's Statement on Comments on the Proposed Rule Change
Received From Members, Participants or Others

    Written comments relating to the proposed rule change have not been
solicited or received. LCH SA will notify the Commission of any written
comments received by LCH SA.

III. Date of Effectiveness of the Proposed Rule Change and Timing for
Commission Action

    Within 45 days of the date of publication of this notice in the
Federal Register or within such longer period up to 90 days (i) as the
Commission may designate if it finds such longer period to be
appropriate and publishes its reasons for so finding or (ii) as to
which the self-regulatory organization consents, the Commission will:
    (A) by order approve or disapprove such proposed rule change, or
    (B) institute proceedings to determine whether the proposed rule
change should be disapproved.

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views, and
arguments concerning the foregoing, including whether the proposed rule
change is consistent with the Act. Comments may be submitted by any of
the following methods:

Electronic Comments

     Use the Commission's internet comment form (http://www.sec.gov/rules/sro.shtml); or
     Send an email to [email protected]. Please include
File Number SR-LCH SA-2022-007 on the subject line.

Paper Comments

     Send paper comments in triplicate to Secretary, Securities
and Exchange Commission, 100 F Street NE, Washington, DC 20549-1090.

All submissions should refer to File Number SR-LCH SA-2022-007. This
file number should be included on the subject line if email is used. To
help the Commission process and review your comments more efficiently,
please use only one method. The Commission will post all comments on
the Commission's internet website (http://www.sec.gov/rules/sro.shtml).
Copies of the submission, all subsequent amendments, all written
statements with respect to the proposed rule change that are filed with
the Commission, and all written communications relating to the proposed
rule change between the Commission and any person, other than those
that may be withheld from the public in accordance with the provisions
of 5 U.S.C. 552, will be available for website viewing and printing in
the Commission's Public Reference Room, 100 F Street NE, Washington, DC
20549 on official business days between the hours of 10:00 a.m. and
3:00 p.m. Copies of the filing also will be available for inspection
and copying at the principal office of LCH SA and on LCH SA's website
at: https://www.lch.com/resources/rulebooks/proposed-rule-changes.
    All comments received will be posted without change. Persons
submitting comments are cautioned that we do not redact or edit
personal identifying information from comment submissions. You should
submit only information that you wish to make available publicly. All
submissions should refer to File Number SR-LCH SA-2022-007 and should
be submitted on or before October 3, 2022.

    For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\23\
---------------------------------------------------------------------------

    \23\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

J. Matthew DeLesDernier,
Deputy Secretary.
[FR Doc. 2022-19579 Filed 9-9-22; 8:45 am]
BILLING CODE 8011-01-P


[Federal Register Volume 77, Number 30 (Tuesday, February 14, 2012)]
[Notices]
[Pages 8325-8326]
[FR Doc No: 2012-3346]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Railroad Administration

[Docket Number FRA-2011-0107]

Petition for Waiver of Compliance

    In accordance with part 213 of title 49 Code of Federal Regulations
(CFR), notice is hereby given that the Federal Railroad Administration
(FRA) has received a request for a waiver of compliance from certain
requirements of its safety standards. By a document dated December 28,
2011, CSX Transportation (CSX) petitions FRA for a waiver from certain
rail testing requirements contained in 49 CFR part 213. FRA assigned
the petition Docket Number FRA-2011-0107.
    Pursuant to 49 CFR Section 213.113(a), CSX requests a waiver from
the accepted practice of stop/start rail testing for phase III of its
nonstop continuous rail test pilot project beginning April 1, 2012, for
a period of up to 1 year on the main tracks between Richmond, VA, and
Charleston, SC. The subdivisions that would be traversed are the North
End, South End, and Charleston.
    Based on the results of the previous phases of nonstop continuous
rail test, CSX will not perform parallel or redundant start/stop rail
testing on track segments being nonstop continuous rail tested under
this waiver. Instead, CSX proposes to produce nonstop continuous rail
test reports every 2 weeks for review by FRA's Rail and Infrastructure
Integrity Division. As CSX develops confidence in the performance of
the system, and as agreed by CSX and FRA, it proposes to expand the
test area to include the tracks between Richmond, VA, and Jacksonville,
FL, and test on a monthly basis.
    The nonstop continuous high-speed rail test vehicle will be a self-
propelled ultrasonic/induction flaw detection vehicle operating at
speeds up to 30 mph. This vehicle will be making runs every 2 weeks
over the assigned territory. Upon completion of each run, data will be
analyzed offline by a group of experts with experience in this process.
The analysis will categorize and prioritize suspect defective locations
for post-test verification. Verifiers will then be sent out with field
instruments to check these suspect locations based upon Global
Positioning System (GPS) coordinates. All suspect locations will be
checked 60 feet on either side of the suspect GPS location. Remedial
actions will be applied, as per 49 CFR Section 213.113, for confirmed
rail defects. CSX believes that nonstop continuous rail testing will
provide the capability to test track more quickly and frequently, and
minimize the risk of rail service failures.
    Interested parties are invited to participate in these proceedings
by submitting written views, data, or comments. FRA does not anticipate
scheduling a public hearing in connection with these proceedings since
the facts do not appear to warrant a hearing. If any interested party
desires an opportunity for oral comment, they should notify FRA, in
writing, before the end of the comment period and specify the basis for
their request.
    All communications concerning these proceedings should identify the
appropriate docket number (e.g., Waiver Petition Docket Number FRA-
2011-0107) and may be submitted by any of the following methods:
     Web site: http://www.regulations.gov. Follow the online
instructions for submitting comments.
     Fax:<PHONE_NUMBER>.
     Mail: Docket Operations Facility, U.S. Department of
Transportation, 1200 New Jersey Avenue SE., W12-140, Washington, DC
20590.
     Hand Delivery: 1200 New Jersey Avenue SE., Room W12-140,
Washington, DC 20590, between 9 a.m. and 5 p.m., Monday through Friday,
except Federal Holidays.
    Communications received within 45 days of the date of this notice
will be considered by FRA before final action is

taken. Comments received after that date will be considered as far as
practicable. All written communications concerning these proceedings
are available for examination during regular business hours (9:00 a.m.-
5:00 p.m.) at the above facility. All documents in the public docket
are also available for inspection and copying on the Internet at the
docket facility's Web site at http://www.regulations.gov.
    Anyone is able to search the electronic form of any written
communications and comments received into any of our dockets by the
name of the individual submitting the comment (or signing the comment,
if submitted on behalf of an association, business, labor union, etc.).
You may review DOT's complete Privacy Act Statement in the Federal
Register published on April 11, 2000 (Volume 65, Number 70; Pages
19477-78).

    Issued in Washington, DC, on February 8, 2012.
Ron Hynes,
Acting Deputy Associate Administrator for Regulatory and Legislative
Operations.
[FR Doc. 2012-3346 Filed 2-13-12; 8:45 am]
BILLING CODE 4910-06-P


[Federal Register Volume 88, Number 135 (Monday, July 17, 2023)]
[Notices]
[Pages 45413-45414]
[FR Doc No: 2023-15051]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings #1

    Take notice that the Commission received the following exempt
wholesale generator filings:
    Docket Numbers: EG23-223-000.
    Applicants: Vineyard Wind 1 LLC.
    Description: Vineyard Wind 1 LLC submits Notice of Self-
Certification of Exempt Wholesale Generator Status.
    Filed Date: 7/11/23.
    Accession Number: 20230711-5001.
    Comment Date: 5 p.m. ET 8/1/23.

    Docket Numbers: EG23-224-000.
    Applicants: Derby Fuel Cell, LLC.
    Description: Derby Fuel Cell, LLC submits Notice of Self-
Certification of Exempt Wholesale Generator Status.
    Filed Date: 7/11/23.
    Accession Number: 20230711-5060.
    Comment Date: 5 p.m. ET 8/1/23.

    Take notice that the Commission received the following electric
rate filings:

    Docket Numbers: ER18-1182-006.
    Applicants: System Energy Resources, Inc.
    Description: Compliance filing: SERI Deficiency Response (ER18-1182
and EL23-11) to be effective 12/31/9998.
    Filed Date: 7/11/23.
    Accession Number: 20230711-5014.
    Comment Date: 5 p.m. ET 8/1/23.

    Docket Numbers: ER21-2892-003.
    Applicants: Prairie Wolf Solar, LLC.
    Description: Compliance filing: Revised Tariff Records in Docket
ER21-2892 to be effective 12/1/2021.
    Filed Date: 7/11/23.
    Accession Number: 20230711-5046.
    Comment Date: 5 p.m. ET 8/1/23.

    Docket Numbers: ER23-1851-001.
    Applicants: PJM Interconnection, L.L.C.
    Description: Tariff Amendment: Response to Deficiency Letter in
ER23-1851-000 to be effective 7/8/2023.
    Filed Date: 7/10/23.
    Accession Number: 20230710-5156.
    Comment Date: 5 p.m. ET 7/31/23.

    Docket Numbers: ER23-1905-001.
    Applicants: PJM Interconnection, L.L.C.
    Description: Tariff Amendment: Request to Defer Action: ISA No.
6914; Queue NQ178; Docket ER23-1905 to be effective 12/31/9998.
    Filed Date: 7/10/23.
    Accession Number: 20230710-5157.
    Comment Date: 5 p.m. ET 7/31/23.

    Docket Numbers: ER23-2365-000.
    Applicants: PJM Interconnection, L.L.C.
    Description: Tariff Amendment: Notice of Cancellation of WMPA,
Service Agreement No. 6230; Queue No. AG1-315 to be effective 9/11/
2023.

    Filed Date: 7/11/23.
    Accession Number: 20230711-5004.
    Comment Date: 5 p.m. ET 8/1/23.

    Docket Numbers: ER23-2366-000.
    Applicants: Virginia Electric and Power Company, PJM
Interconnection, L.L.C.
    Description: Sec.  205(d) Rate Filing: Virginia Electric and Power
Company submits tariff filing per 35.13(a)(2)(iii: VEPCO submits one
WDSA, SA No. 6996 to be effective 6/15/2023.
    Filed Date: 7/11/23.
    Accession Number: 20230711-5026.
    Comment Date: 5 p.m. ET 8/1/23.

    Docket Numbers: ER23-2367-000.
    Applicants: Wildflower Solar 2 LLC.
    Description: Baseline eTariff Filing: Certificate of Concurrence to
be effective 9/6/2023.
    Filed Date: 7/11/23.
    Accession Number: 20230711-5106.
    Comment Date: 5 p.m. ET 8/1/23.

    Docket Numbers: ER23-2368-000.
    Applicants: Derby Fuel Cell, LLC.
    Description: Baseline eTariff Filing: Baseline new to be effective
7/12/2023.
    Filed Date: 7/11/23.
    Accession Number: 20230711-5113.
    Comment Date: 5 p.m. ET 8/1/23.

    The filings are accessible in the Commission's eLibrary system
(https://elibrary.ferc.gov/idmws/search/fercgensearch.asp) by querying
the docket number.
    Any person desiring to intervene, to protest, or to answer a
complaint in any of the above proceedings must file in accordance with
Rules 211, 214, or 206 of the Commission's Regulations (18 CFR 385.211,
385.214, or 385.206) on or before 5:00 p.m. Eastern time on the
specified comment date. Protests may be considered, but intervention is
necessary to become a party to the proceeding.
    eFiling is encouraged. More detailed information relating to filing
requirements, interventions, protests, service, and qualifying
facilities filings can be found at: http://www.ferc.gov/docs-filing/efiling/filing-req.pdf. For other information, call<PHONE_NUMBER>
(toll free). For TTY, call<PHONE_NUMBER>.
    The Commission's Office of Public Participation (OPP) supports
meaningful public engagement and participation in Commission
proceedings. OPP can help members of the public, including landowners,
environmental justice communities, Tribal members and others, access
publicly available information and navigate Commission processes.
    For public inquiries and assistance with making filings such as
interventions, comments, or requests for rehearing, the public is
encouraged to contact OPP at<PHONE_NUMBER> or [email protected].

    Dated: July 11, 2023.
Debbie-Anne A. Reese,
Deputy Secretary.
[FR Doc. 2023-15051 Filed 7-14-23; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 79, Number 162 (Thursday, August 21, 2014)]
[Proposed Rules]
[Page 49465]
[FR Doc No: 2014-19831]

========================================================================
Proposed Rules
                                                Federal Register
________________________________________________________________________

This section of the FEDERAL REGISTER contains notices to the public of
the proposed issuance of rules and regulations. The purpose of these
notices is to give interested persons an opportunity to participate in
the rule making prior to the adoption of the final rules.

========================================================================

Federal Register / Vol. 79, No. 162 / Thursday, August 21, 2014 /
Proposed Rules

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 573

[Docket No. FDA-2014-F-1184]

Zinpro Corp.; Filing of Food Additive Petition (Animal Use)

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of petition.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that
Zinpro Corp. has filed a petition proposing that the food additive
regulations be amended to provide for the safe use of zinc L-
selenomethionine as a source of selenium in complete feed for broiler
chickens.

DATES: Submit either electronic or written comments on the petitioner's
request for categorical exclusion from preparing an environmental
assessment or environmental impact statement by September 22, 2014.

ADDRESSES: Submit electronic comments to: http://www.regulations.gov.
Submit written comments to the Division of Dockets Management (HFA-
305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT: Isabel W. Pocurull, Center for
Veterinary Medicine (HFV-226), Food and Drug Administration, 7519
Standish Pl., Rockville, MD 20855,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION: Under the Federal Food, Drug, and Cosmetic
Act (section 409(b)(5) (21 U.S.C. 348(b)(5)), notice is given that a
food additive petition (FAP 2285) has been filed by Zinpro Corp., 10400
Viking Dr., Suite 240, Eden Prairie, MN 55344. The petition proposes to
amend Title 21 of the Code of Federal Regulations (CFR) in part 573
Food Additives Permitted in Feed and Drinking Water of Animals (21 CFR
part 573) to provide for the safe use of zinc L-selenomethionine as a
source of selenium in complete feed for broiler chickens.
    The petitioner has requested a categorical exclusion from preparing
an environmental assessment or environmental impact statement under 21
CFR 25.32(r). Interested persons may submit either electronic or
written comments regarding this request for categorical exclusion to
the Division of Dockets Management (see DATES and ADDRESSES). It is
only necessary to send one set of comments. Identify comments with the
docket number found in brackets in the heading of this document.
Received comments may be seen in the Division of Dockets Management
between 9 a.m. and 4 p.m., Monday through Friday, and will be posted to
the docket at http://www.regulations.gov.

    Dated: August 15, 2014.
Bernadette Dunham,
Director, Center for Veterinary Medicine.
[FR Doc. 2014-19831 Filed 8-20-14; 8:45 am]
BILLING CODE 4164-01-P


[Federal Register Volume 81, Number 55 (Tuesday, March 22, 2016)]
[Notices]
[Pages 15297-15298]
[FR Doc No: 2016-06369]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings #2

    Take notice that the Commission received the following electric
corporate filings:

    Docket Numbers: EC16-70-000.
    Applicants: Portsmouth Genco, LLC, Virginia Renewable Power--
Portsmouth, LLC.
    Description: Supplement to February 12, 2016 Application for
Authorization for Disposition of Jurisdictional Facilities of
Portsmouth Genco, LLC, et al.
    Filed Date: 3/16/16.
    Accession Number: 20160316-5133.
    Comments Due: 5 p.m. ET 3/28/16.

    Docket Numbers: EC16-84-000.
    Applicants: Kingbird Solar A, LLC, Kingbird Solar B, LLC.
    Description: Supplement to March 1, 2016 Application for
Authorization Under Section 203 of the Federal Power Act of Kingbird
Solar A, LLC, et al.
    Filed Date: 3/16/16.
    Accession Number: 20160316-5135.
    Comments Due: 5 p.m. ET 3/28/16.

    Docket Numbers: EC16-87-000.
    Applicants: Judith Gap Energy LLC, Spring Canyon Energy LLC,
Wolverine Creek Energy LLC, Wolverine Creek Goshen Interconnection LLC.
    Description: Application for Authorization under Section 203 of the
Federal Power Act and Request for Waivers and Expedited Action of
Judith Gap Energy LLC, et al.
    Filed Date: 3/16/16.
    Accession Number: 20160316-5063.
    Comments Due: 5 p.m. ET 4/6/16.

    Take notice that the Commission received the following exempt
wholesale generator filings:

    Docket Numbers: EG16-74-000.
    Applicants: Ninnescah Wind Energy, LLC.
    Description: Notice of Self-Certification of Exempt Wholesale
Generator Status of Ninnescah Wind Energy, LLC.
    Filed Date: 3/15/16.
    Accession Number: 20160315-5140.
    Comments Due: 5 p.m. ET 4/5/16.

    Take notice that the Commission received the following electric
rate filings:

    Docket Numbers: ER14-474-006.
    Applicants: Sempra Generation, LLC.
    Description: Notice of Non-Material Change in Status of Sempra
Generation, LLC.
    Filed Date: 3/15/16.
    Accession Number: 20160315-5159.
    Comments Due: 5 p.m. ET 4/5/16.

    Docket Numbers: ER15-1905-003.
    Applicants: Amazon Energy, LLC.
    Description: Compliance filing: Amazon Energy, LLC Tariff Amendment
to be effective 3/16/2016.
    Filed Date: 3/15/16.
    Accession Number: 20160315-5000.
    Comments Due: 5 p.m. ET 4/5/16.

    Docket Numbers: ER16-207-002.
    Applicants: Dynegy Oakland, LLC.
    Description: Tariff Amendment: Settlement Agreement and Request for
Expedited Treatment to be effective 1/1/2016.
    Filed Date: 3/14/16.
    Accession Number: 20160314-5227.
    Comments Due: 5 p.m. ET 4/4/16.

    Docket Numbers: ER16-895-001.
    Applicants: RDAF Energy Solutions, LLC.
    Description: Tariff Amendment: Amendment of RDAF Baseline Filing
For MBR Authority and Granting Waivers to be effective 3/15/2016.
    Filed Date: 3/15/16.
    Accession Number: 20160315-5073.
    Comments Due: 5 p.m. ET 4/5/16.

    Docket Numbers: ER16-904-001.
    Applicants: Smith Creek Hydro, LLC.
    Description: Amendment to February 5, 2016 and March 4, 2016 Smith
Creek Hydro, LLC tariff filings.
    Filed Date: 3/16/16.
    Accession Number: 20160316-5076.
    Comments Due: 5 p.m. ET 3/23/16.

    Docket Numbers: ER16-1129-001.
    Applicants: VPI Enterprises, Inc.
    Description: Tariff Amendment: Supplement to Application for Order
Accepting Initial Market-Based Rate Tariff to be effective 3/11/2016.

    Filed Date: 3/16/16.
    Accession Number: 20160316-5098.
    Comments Due: 5 p.m. ET 4/6/16.

    Docket Numbers: ER16-1130-001.
    Applicants: DifWind Farms Limited I.
    Description: Tariff Amendment: Supplement to Application for Order
Accepting Initial Market-Based Rate Tariff to be effective 3/11/2016.
    Filed Date: 3/16/16.
    Accession Number: 20160316-5097.
    Comments Due: 5 p.m. ET 4/6/16.

    Docket Numbers: ER16-1131-001.
    Applicants: DifWind Farms Limited II.
    Description: Tariff Amendment: Supplement to Application for Order
Accepting Initial Market-Based Rate Tariff to be effective 3/11/2016.
    Filed Date: 3/16/16.
    Accession Number: 20160316-5096.
    Comments Due: 5 p.m. ET 4/6/16.

    Docket Numbers: ER16-1132-001.
    Applicants: DifWind Farms Limited V.
    Description: Tariff Amendment: Supplement to Application for Order
Accepting Initial Market-Based Rate Tariff to be effective 3/11/2016.
    Filed Date: 3/16/16.
    Accession Number: 20160316-5094.
    Comments Due: 5 p.m. ET 4/6/16.

    Docket Numbers: ER16-1189-000.
    Applicants: RE Mustang 3 LLC.
    Description: Sec.  205(d) Rate Filing: RE Mustang 3 LLC Certificate
of Concurrence for LGIA Co-Tenancy Agreement to be effective 4/26/2016.
    Filed Date: 3/15/16.
    Accession Number: 20160315-5116.
    Comments Due: 5 p.m. ET 4/5/16.

    Docket Numbers: ER16-1190-000.
    Applicants: RE Mustang 3 LLC.
    Description: Sec.  205(d) Rate Filing: RE Mustang 3 LLC Certificate
of Concurrence for Shared Facilities Agreement to be effective 4/26/
2016.
    Filed Date: 3/15/16.
    Accession Number: 20160315-5117.
    Comments Due: 5 p.m. ET 4/5/16.

    Docket Numbers: ER16-1191-000.
    Applicants: RE Mustang 4 LLC.
    Description: Sec.  205(d) Rate Filing: RE Mustang 4 LLC Certificate
of Concurrence for LGIA Co-Tenancy Agreement to be effective 4/26/2016.
    Filed Date: 3/15/16.
    Accession Number: 20160315-5118.
    Comments Due: 5 p.m. ET 4/5/16.

    Docket Numbers: ER16-1192-000.
    Applicants: RE Mustang 4 LLC.
    Description: Sec.  205(d) Rate Filing: RE Mustang 4 LLC Certificate
of Concurrence for Shared Facilities Agreement to be effective 4/26/
2016.
    Filed Date: 3/15/16.
    Accession Number: 20160315-5119.
    Comments Due: 5 p.m. ET 4/5/16.

    Docket Numbers: ER16-1193-000.
    Applicants: Western Antelope Blue Sky Ranch A LLC.
    Description: Sec.  205(d) Rate Filing: Western Antelope Blue Sky
Ranch A LLC Amended SFA to be effective 3/17/2016.
    Filed Date: 3/16/16.
    Accession Number: 20160316-5000.
    Comments Due: 5 p.m. ET 4/6/16.

    Docket Numbers: ER16-1194-000.
    Applicants: Sierra Solar Greenworks LLC.
    Description: Sec.  205(d) Rate Filing: Sierra Solar Greenworks LLC
SFA to be effective 3/17/2016.
    Filed Date: 3/16/16.
    Accession Number: 20160316-5001.
    Comments Due: 5 p.m. ET 4/6/16.

    Docket Numbers: ER16-1195-000.
    Applicants: Central Antelope Dry Ranch C LLC.
    Description: Baseline eTariff Filing: Central Antelope Dry Ranch C
LLC SFA to be effective 3/17/2016.
    Filed Date: 3/16/16.
    Accession Number: 20160316-5002.

    Docket Numbers: ER16-1201-000.
    Applicants: Southwest Power Pool, Inc.
    Description: Sec.  205(d) Rate Filing: 3179 Transource Missouri &
OPPD Interconnection Agreement to be effective 2/18/2016.
    Filed Date: 3/16/16.
    Accession Number: 20160316-5100.
    Comments Due: 5 p.m. ET 4/6/16.
    Docket Numbers: ER16-1202-000.
    Applicants: The Energy Group of America, Inc.
    Description: Baseline eTariff Filing: MBR Application to be
effective 5/15/2016.
    Filed Date: 3/16/16.
    Accession Number: 20160316-5102.
    Comments Due: 5 p.m. ET 4/6/16.

    Docket Numbers: ER16-1203-000.
    Applicants: RE Astoria LLC.
    Description: Sec.  205(d) Rate Filing: Astoria-Willow Springs
Shared Facilities Agreement to be effective 3/27/2016.
    Filed Date: 3/16/16.
    Accession Number: 20160316-5138.
    Comments Due: 5 p.m. ET 4/6/16.

    Docket Numbers: ER16-1204-000.
    Applicants: Wisconsin Public Service Corporation.
    Description: Sec.  205(d) Rate Filing: Wisconsin Public Service
Corporation's Annual PEB/PBOP Filing to be effective 4/1/2016.
    Filed Date: 3/16/16.
    Accession Number: 20160316-5142.
    Comments Due: 5 p.m. ET 4/6/16.

    Docket Numbers: ER16-1205-000.
    Applicants: AEP Texas North Company.
    Description: Sec.  205(d) Rate Filing: TNC-Southwest Texas EC-
Golden Spread EC IA Fourth Amend & Restated to be effective 3/1/2016.
    Filed Date: 3/16/16.
    Accession Number: 20160316-5144.
    Comments Due: 5 p.m. ET 4/6/16.

    Docket Numbers: ER16-1206-000.
    Applicants: Northern States Power Company, a Wisconsin corporation,
Northern States Power Company, a Minnesota corporation.
    Description: Sec.  205(d) Rate Filing: 20160316_IA_Annual to be
effective 1/1/2016.
    Filed Date: 3/16/16.
    Accession Number: 20160316-5145.
    Comments Due: 5 p.m. ET 4/6/16.

    Docket Numbers: ER16-1207-000.
    Applicants: Michigan Electric Transmission Company, LLC.
    Description: Sec.  205(d) Rate Filing: Filing of Third Amended and
Restated Service Agreement to be effective 6/1/2016.
    Filed Date: 3/16/16.
    Accession Number: 20160316-5149.
    Comments Due: 5 p.m. ET 4/6/16.

    Docket Numbers: ER16-1208-000.
    Applicants: Idaho Power Company.
    Description: Sec.  205(d) Rate Filing: Attachment K Version
Correction to be effective 1/1/2016.
    Filed Date: 3/16/16.
    Accession Number: 20160316-5151.
    Comments Due: 5 p.m. ET 4/6/16.

    The filings are accessible in the Commission's eLibrary system by
clicking on the links or querying the docket number.
    Any person desiring to intervene or protest in any of the above
proceedings must file in accordance with Rules 211 and 214 of the
Commission's Regulations (18 CFR 385.211 and 385.214) on or before 5:00
p.m. Eastern time on the specified comment date. Protests may be
considered, but intervention is necessary to become a party to the
proceeding.
    eFiling is encouraged. More detailed information relating to filing
requirements, interventions, protests, service, and qualifying
facilities filings can be found at: http://www.ferc.gov/docs-filing/efiling/filing-req.pdf. For other information, call<PHONE_NUMBER>
(toll free). For TTY, call<PHONE_NUMBER>.

    Dated: March 16, 2016.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2016-06369 Filed 3-21-16; 8:45 am]
 BILLING CODE 6717-01-P